Paid Clinical Trials in La Crosse, WI
As of August 2026, 95 paid clinical trials are recruiting in La Crosse, Wisconsin. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
La Crosse offers studies at sites including Gundersen Lutheran Medical Center for conditions such as Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Breast Cancer, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in La Crosse
Trials by drug in La Crosse
Filter results
93 clinical trials
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Prevail Global Study
GEMINI-NSCLC: NSCLC Biomarker Study
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
A Study of Methylprednisolone in People Having Liver Surgery
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Top Research Study Locations in La Crosse
Researchers run research studies in La Crosse, WI at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Gundersen Lutheran Medical Center | Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Lung Non-Small Cell Carcinoma | 63 |
| Mayo Clinic Health System-Franciscan Healthcare | Stage III Prostate Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 11 |
| Gundersen Health System | Geographic Atrophy Secondary to Age-related Macular Degeneration, Amblyopia, Arthroplasties, Knee Replacement | 7 |
| Gundersen Health System, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Gundersen Lutheran | Coronary Artery Disease, Multiple Myeloma | 2 |
| Gundersen | Extensive Stage Lung Small Cell Cancer | 1 |
| Gundersen Health | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Gundersen Health System - La Crosse Medical Center | Autoimmune Haemolytic Anaemia | 1 |
| Gundersen Lutheran Medical Foundation | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Gundersen Lutheran Medical Foundation (Data Collection Only) | Hepatectomy | 1 |
| Gunderson Health | Breast Cancer, Early Stage Breast Cancer, HER2 + Breast Cancer | 1 |
| Gunderson Health System | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 1 |
| La Crosse Mayo Clinic | Alzheimer Disease and Related Dementias (ADRD), Hearing Loss, Mild Cognitive Impairment | 1 |
| Mayo Clinic Health System - La Crosse | Breast Cancer | 1 |
| Mayo Clinic Health System - Southwest Wisconsin | Adnexal Mass, Atypical Endometrial Hyperplasia, Cervical Cancer | 1 |
| Mayo Clinic Health System SW Wisconsin | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 1 |
| Mayo Clinic Health System- La Crosse | Lumbar Spinal Stenosis | 1 |
| Mayo Clinic Health System-La Crosse | Community-acquired Pneumonia | 1 |
| University of Wisconsin La Crosse | Inflammation, Peripheral Arterial Disease, Walking, Difficulty | 1 |
Active & Upcoming Studies in La Crosse (2026)
Recruiting trials in La Crosse grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (71 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma · Phase 3 · PrECOG, LLC.
Neurology & pain (3 active studies)
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine · Phase 3 · Merz Therapeutics GmbH
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine · Phase 3 · Merz Therapeutics GmbH
Eye & vision (3 active studies)
- An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) · Phase 1, Phase 2 · Complement Therapeutics
- A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) · Complement Therapeutics
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (2 active studies)
- Prevail Global Study · Medtronic Vascular
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Common conditions studied in La Crosse
- Stage IV Lung Cancer AJCC v8 (6 active studies)
- Acute Myeloid Leukemia (5 active studies)
- Breast Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IIIB Lung Cancer AJCC v8 (4 active studies)
Leading research sponsors in La Crosse
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Mayo Clinic
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in La Crosse?
There are approximately 95 recruiting clinical trials in La Crosse, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in La Crosse pay participants?
Most recruiting trials in La Crosse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in La Crosse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in La Crosse?
The most common conditions under active study in La Crosse include Stage IV Lung Cancer AJCC v8 (6), Acute Myeloid Leukemia (5), Breast Cancer (4), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in La Crosse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Crosse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in La Crosse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in La Crosse?
Recruiting research sites in La Crosse include Gundersen Lutheran Medical Center, Mayo Clinic Health System-Franciscan Healthcare, Gundersen Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in La Crosse right now?
The largest active categories in La Crosse are Cancer & tumors (71), Neurology & pain (3), Eye & vision (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.